10x Genomics Inc.
TXGUnited States
36 filed reports · 381 financial concepts · 12 earnings calls · 3 media appearances
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Filed reports
36 reports · Sep 2019 to Sep 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 14 guidance figures, 32 earnings-release figures, 34 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 22 | 3,956 | Sep 2019 to Sep 2026 |
| Annual · 10-KSEC EDGAR | 7 | 3,351 | Dec 2019 to Dec 2025 |
| Current · 8-KSEC EDGAR | 7 | 20 | Sep 2019 to Sep 2026 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q3 | 10-Q | 2026-09-30 | 2026-11-06 | 377 | Open |
| FY2026 Q3 | 8-K | 2026-09-30 | 2026-11-05 | 6 | Open |
| FY2026 Q2 | 10-Q | 2026-06-30 | 2026-08-07 | 238 | Open |
| FY2026 Q2 | 8-K | 2026-06-30 | 2026-08-06 | 4 | Open |
| FY2026 Q1 | 10-Q | 2026-03-31 | 2026-05-08 | 234 | Open |
| FY2025 | 10-K | 2025-12-31 | 2026-02-13 | 891 | Open |
| FY2025 Q3 | 10-Q | 2025-09-30 | 2025-11-07 | 181 | Open |
| FY2025 Q2 | 10-Q | 2025-06-30 | 2025-08-08 | 153 | Open |
| FY2025 Q1 | 10-Q | 2025-03-31 | 2025-05-09 | 149 | Open |
| FY2024 | 10-K | 2024-12-31 | 2025-02-13 | 439 | Open |
| FY2024 Q3 | 10-Q | 2024-09-30 | 2024-10-29 | 165 | Open |
| FY2024 Q2 | 10-Q | 2024-06-30 | 2024-08-08 | 151 | Open |
Financial data
381 concepts · 7,327 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial375 concepts · 6,784 facts · Dec 2017 to Sep 2026
- Accrued legal and related costs45 · Dec 2018 to Sep 2026
- Stockholders equity (US GAAP)45 · Dec 2017 to Sep 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value44 · Dec 2017 to Sep 2026
- Gross profit (US GAAP)44 · Dec 2017 to Sep 2026
- Net income loss44 · Dec 2017 to Sep 2026
- Other comprehensive income loss net of tax portion attributable to parent44 · Dec 2017 to Sep 2026
- Revenue44 · Dec 2017 to Sep 2026
- Cash cash equivalents restricted cash and restricted cash equivalents43 · Dec 2017 to Sep 2026
- Allocated share based compensation expense42 · Dec 2017 to Sep 2026
- Comprehensive income net of tax42 · Dec 2017 to Sep 2026
- Cost of revenue (US GAAP)42 · Dec 2017 to Sep 2026
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest42 · Dec 2017 to Sep 2026
- Income tax expense benefit42 · Dec 2017 to Sep 2026
- Investment income interest42 · Dec 2017 to Sep 2026
- Nonoperating income expense42 · Dec 2017 to Sep 2026
- Operating expenses (US GAAP)42 · Dec 2017 to Sep 2026
- Operating income loss42 · Dec 2017 to Sep 2026
- Other nonoperating income expense42 · Dec 2017 to Sep 2026
- Research and development expense excluding acquired in process cost42 · Dec 2017 to Sep 2026
- Selling general and administrative expense42 · Dec 2017 to Sep 2026
- Accrued expenses and other current liabilities41 · Dec 2017 to Sep 2026
- Capital expenditures incurred but not yet paid41 · Dec 2017 to Sep 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect41 · Dec 2017 to Sep 2026
- Depreciation depletion and amortization41 · Dec 2017 to Sep 2026
Geography1 concept · 260 facts · Dec 2017 to Sep 2026
- Revenue260 · Dec 2017 to Sep 2026
Product1 concept · 257 facts · Dec 2017 to Sep 2026
- Revenue257 · Dec 2017 to Sep 2026
Guidance3 concepts · 18 facts · Nov 2019 to Nov 2026
- Revenue Guidance14 · Nov 2019 to Nov 2026
- Revenue Growth Guidance2 · Aug 2026
- Revenue Growth Guidance (Adjusted (non-GAAP))2 · Nov 2026
KPI1 concept · 8 facts · Dec 2021 to Dec 2025
- Deliveries8 · Dec 2021 to Dec 2025
Segments
517 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographical9 members · 260 facts
- CN42 · Dec 2017 to Sep 2026
- EMEA42 · Dec 2017 to Sep 2026
- Asia Pacific38 · Dec 2017 to Sep 2026
- Asia Pacific Excluding China31 · Mar 2020 to Sep 2026
- US30 · Dec 2019 to Sep 2026
- Americas24 · Dec 2021 to Sep 2026
- Americas Excluding United States24 · Dec 2021 to Sep 2026
- North America17 · Dec 2017 to Sep 2021
- North America Excluding United States12 · Dec 2019 to Dec 2022
Product or service12 members · 257 facts
- Consumables42 · Dec 2017 to Sep 2026
- Service42 · Dec 2017 to Sep 2026
- Instruments34 · Mar 2019 to Sep 2026
- Spatial Consumables24 · Dec 2021 to Sep 2026
- Spatial Instruments24 · Dec 2021 to Sep 2026
- Chromium Consumables22 · Dec 2021 to Sep 2026
- Chromium Instruments22 · Dec 2021 to Sep 2026
- Licensing And Royalty Revenue14 · Dec 2023 to Sep 2026
- Product And Service Revenue14 · Dec 2023 to Sep 2026
- Instuments13 · Dec 2017 to Dec 2022
- Single Cell Consumables3 · Dec 2023 to Dec 2025
- Single Cell Instruments3 · Dec 2023 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary89 claims from 12 reports · Sep 2024 to Sep 2026
- Management discussion (MD&A) commentary171 claims from 9 reports · Sep 2024 to Sep 2026
- Risk-factor changes139 claims from 6 reports · Dec 2020 to Dec 2025
- Risk factors456 risks from 7 annual reports · 2019 to 2025
Earnings calls
12 calls · Feb 2024 to Nov 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q32026-11-05
- FY2026 Q22026-08-06
- FY2026 Q12026-05-07
- FY2025 Q42026-02-12
- FY2025 Q32025-11-06
- FY2025 Q22025-08-09
- FY2025 Q12025-05-08
- FY2024 Q42025-02-12
- FY2024 Q32024-10-29
- FY2024 Q22024-08-08
- FY2024 Q12024-04-30
- FY2023 Q42024-02-15
Executive media
3 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances2 · Sep 2022 to Apr 2026
- TV interviews1 · Oct 2020
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of 10x Genomics Inc. (TXG) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.